Sanofi India Ltd has reported financial results for the period ended March 31, 2021.
Financial Results (Q1 CY2021) - QoQ Comparison
The company has reported total income of Rs.751.4 crores during the period ended March 31, 2021 (Q1 CY2021) as compared to Rs.736.5 crores during the period ended December 31, 2020 (Q4 CY2020).
The company has posted net profit of Rs.145.9 crores for the period ended March 31, 2021 as against Rs.123 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.63.35 for the period ended March 31, 2021 as compared to Rs.53.41 for the period ended December 31, 2020.
Total Income | ₹ 751.4 crs | ₹ 736.5 crs | 2.02% |
Net Profit | ₹ 145.9 crs | ₹ 123 crs | 18.62% |
EPS | ₹ 63.35 | ₹ 53.41 | 18.61% |
Financial Results (Q1 CY2021) - YoY ComparisonThe company has reported total income of Rs.751.4 crores during the period ended March 31, 2021 (Q1 CY2021) as compared to Rs.814 crores during the period ended March 31, 2019 (Q1 CY2020).
The company has posted net profit of Rs.145.9 crores for the period ended March 31, 2021 as against Rs.85.4 crores for the period ended March 31, 2019.
The company has reported EPS of Rs.63.35 for the period ended March 31, 2021 as compared to Rs.37.08 for the period ended March 31, 2019.
Total Income | ₹ 751.4 crs | ₹ 814 crs | -7.69% |
Net Profit | ₹ 145.9 crs | ₹ 85.4 crs | 70.84% |
EPS | ₹ 63.35 | ₹ 37.08 | 70.85% |
Shares of Sanofi India Ltd was last trading in BSE at Rs.7444 as compared to the previous close of Rs. 7584.75. The total number of shares traded during the day was 4396 in over 1425 trades.
The stock hit an intraday high of Rs. 7690 and intraday low of 7430. The net turnover during the day was Rs. 32921069.
Source : Equity Bulls
Keywords